Notifications process: requests to vary registered medicines where quality, safety and efficacy are not affected
Version 3.0, May 2018
|Version||Description of change||Author||Effective date|
|V1.0||Original publication||TGA||June 2017|
Inclusion of second set of notifiable variations to registered medicines.
Inclusion of notifiable changes to biologicals.
Minor amendments to phrasing to clarify conditions.
Minor amendments to phrasing and typographical errors.
Additional guidance on situations where notifications conditions are not met.